Relation

Results - Study on immunogenicity and safety of Ad5-vectored COVID-19 vaccine in larger population

  • Specific antibody responses to RBD and neutralizing antibodies to live SARS-CoV-2 and pseudovirus
  • Specific T-cell responses
  • Adverse reactions by time

0

1

Updated 2020-10-07

Contributors are:

Who are from:

Tags

SARS-CoV-2 (COVID-19)

Biomedical engineering

Biomedical Sciences